Subcutaneous heparin in postangioplasty management: comparative trial with intravenous heparin. Am Heart J 1993;126:1059-67.Fail P, Maniet A, Banka V. Subcutaneous heparin in post-angioplasty management: comparative trial with intravenous heparin. Am Heart J 1993;126:1059 - 67....
Compares the efficacy between subcutaneous calcium heparin and intravenous sodium heparin on the treatment of patients with established acute deep vein thrombosis in the legs. Difference on the reaction of patients between the two treatments; Complications of the treatment; Advantages of the subcutaneous ...
Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin Tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis. Am J Kidney Dis 2002; 40: 531-538Hainer JW, Sherrard DJ, Swan SK, et al. Intravenous and subcutaneous weight-based ...
To determine the efficacy and safety of subcutaneous low molecular weight heparins in the initial treatment of proximal deep vein thrombosis we reviewed all published randomised controlled studies comparing this treatment to the standard intravenous unfractionated heparin regimen. Adverse events were taken ...
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. We performed a randomized double-blind trial comparing continuous intravenous heparin with intermittent subcutaneous heparin in the initial treatment of 115 patients with acute ...
This was followed by a continuous subcutaneous heparin infusion at a dose of 15 to 25 units per kilogram per hour. Effective levels of anticoagulation were achieved in all five patients. Regulation and maintenance of therapeutic anticoagulation were no more difficult than with intravenous therapy. ...
Based on reports in the literature, the therapy was changed to intravenous unfractionated heparin (UFH), which was effective in controlling the thrombotic coagulopathy. For practical reasons, despite a lack of evidence of its effectiveness in Trousseau’s syndrome, therapy with UFH was changed to ...
The Treatment of Proximal Vein Thrombosis with Subcutaneous Low-Mole Molecular-Weight Heparin Compared with Continuous Intravenous Heparin Low-molecular-weight heparin has a high bioavailability and a prolonged half-life in comparison with conventional unfractionated heparin. Limited data are ... RD Hull,...
•Mortality among streptokinase-treated patients was 8.3% for those who also received intravenous heparin and 9.0% for those receivingsubcutaneousheparin.•The few year-round species of high-arctic birds and mammals make good use of feathers, fur andsubcutaneousinsulation.•A prickling sensation...
We performed a randomized double-blind trial comparing continuous intravenous heparin with intermittent subcutaneous heparin in the initial treatment of 115 patients with acute proximal deep-vein thrombosis. Intermittent subcutaneous heparin as administered in this trial was inferior to continuous intravenous ...